Veterinary Diagnostics Market by Product (Instruments, Consumables), Technology (Immunodiagnostics (ELISA), Molecular Diagnostics (PCR, Microarrays), Hematology), Animal (Dogs, Cats, Cattle, Pigs), End User (Hospitals & Clinics) & Region - Global Forecast to 2027
Updated on : May 17, 2023
The global veterinary diagnostics market in terms of revenue was estimated to be worth $2.8 billion in 2022 and is poised to reach $4.4 billion by 2027, growing at a CAGR of 9.2% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The current edition of the report consists of an updated market overview, which includes information on the key conferences and events during 2022–2023, regulatory bodies, government agencies, and other organizations, as well as the key stakeholders and their buying criteria. The market overview chapters also include regulatory analysis, Porter’s five forces analysis, value chain analysis, supply chain analysis, ecosystem analysis, patent analysis, adjacent market analysis, and pricing analysis. The competitive landscape chapter has been updated with the competitive benchmarking segment. Market growth can largely be attributed to growing animal health expenditures, increasing disease control and disease prevention measures, and growth in the number of veterinary practitioners and income levels in developed economies. The availability of advanced diagnostic technologies is expected to help veterinarians provide better diagnosis and treatment, which, in turn, will drive the overall market for veterinary diagnostics across the globe. In addition, continuous innovations will enable market players to gain a long-term competitive advantage, further strengthening their positions in the global market.
To know about the assumptions considered for the study, Request for Free Sample Report
Veterinary Diagnostics Market Dynamics
Driver: Increasing disease control and disease prevention measures
With previous epidemic outbreaks, there has been increased vigilance regarding the re-emergence of diseases that have been declared eradicated. In 2011, rinderpest (caused by the virus Rinderpest Morbillivirus) was declared eradicated by the UN FAO and the World Organization for Animal Health (OIE). However, both agencies urged countries to remain vigilant for its re-emergence. The Global Rinderpest Action Plan includes optimising diagnostic tools to help in emergencies, which involves constant diagnostic checks as a preventive measure.
Furthermore, according to the US Centers for Disease Control and Prevention (CDC), in 2019, eight major zoonotic breakouts were reported. Every year, thousands of Americans get sick from diseases spread between animals and people. Six out of every ten diseases in humans are zoonotic, making it crucial that nations strengthen their respective capabilities to prevent and respond to these diseases. This intensifies the need for regular monitoring of animal health, especially livestock. Consequently, it can be expected that the growing prevalence and incidence of animal diseases will boost the demand for innovative diagnostic products to detect, monitor, and limit disease outbreaks. The availability of advanced diagnostic technologies is expected to help veterinarians provide better diagnosis and treatment, which will drive the overall market for veterinary diagnostics worldwide. Additionally, continuous research, innovations, and awareness programmes will enable market players to gain long-term competitive advantages, thus strengthening their positions in the veterinary diagnostics market.
Opportunity: Increased use of PCR testing panels to rule out the COVID-19 virus in animals
Amidst the current COVID-19 pandemic, animal health authorities have been carrying out tests to understand how the virus affects animals. So far, research studies have shown that felines are more susceptible than other animals. Testing also shows that the virus spreads less from animal to animal as opposed to human-human or human-animal.
The most recent development in this market is the introduction of a PCR panel by IDEXX and Zoetis in April 2020. These tests can be used to test the COVID-19 virus in animals and are commercially available to veterinarians and pet owners. However, these tests are not recommended for routine diagnostic purposes by the AVMA. This test can be ordered if all alternative disease cases have been ruled out. It is expected that pet owners will increasingly start testing their pets for the absence of these diseases, thus increasing the demand for PCR panels for virus testing. This will create opportunities for new molecular diagnostic panels in the industry.
Restraint: High cost of veterinary diagnostics test
The high cost of advanced diagnostic tests is a major barrier that hinders the adoption of veterinary diagnostics. According to the CDC, in 2019, the estimated public health expenditure on rabies disease diagnostics, prevention, and control in the US was between USD 245 and USD 510 million annually. This estimate is based on available data on the costs associated with the vaccination of companion animals (dogs and cats), national rabies diagnostic testing, and biologics for rabies postexposure prophylaxis (PEP) and preexposure prophylaxis (PreEP). However, the total expenditure on rabies (including healthcare costs and animal control measures) is much greater.
Veterinary diagnostic imaging systems are also expensive products. Small portable machines start at around USD 2,000–3,000 and reach USD 50,000, with added costs of backup transducer probes going up to USD 1,000 and printers up to USD 2,000 on average. Most veterinary practises are small or medium-sized, with strict budgetary constraints. The high cost of these tests and systems, therefore, is a major market restraint. The lack of reimbursement for veterinary procedures is another factor limiting the uptake of veterinary diagnostics, thus restraining the growth of this market.
Challenge: Lack of animal healthcare awareness in emerging countries
Emerging economies such as India, China, Brazil, and some Southeast Asian countries are home to a large companion and farm animal population. However, animal health expenditure in these countries is lower than in developed North American and European countries. This is mainly due to a lack of awareness among pet owners and veterinarians about the healthcare services available for animals. Furthermore, these countries' farm animal health expenditure is primarily focused on therapeutic treatment. Veterinary diagnostics are not widely used in large animal practises in these countries. Thus, although emerging markets have a high growth potential, lack of awareness will be a key challenge for the growth of the veterinary diagnostics market in these regions.
The consumables segment is expected to register the highest CAGR in the veterinary diagnostics market during the forecast period
Based on products, the market is segmented into consumables and instruments. The consumables segment is expected to register the highest CAGR during the forecast period. The increasing incidence of new infectious diseases such as SARS-CoV-2 viral infection and the increasing demand for rapid diagnostics in animals are driving the growth of this market.
The clinical biochemistry segment is expected to register the highest CAGR in the veterinary diagnostics market during the forecast period
Based on technology, the market is segmented into clinical biochemistry, immunodiagnostics, molecular diagnostics, hematology, urinalysis, and other veterinary diagnostic technologies (including microbiology and histopathology tests). The clinical biochemistry segment is expected to register the highest CAGR during the forecast period. In the veterinary industry, clinical biochemistry analysis is conducted to diagnose diseases, screen disease progression, and monitor responses to therapy, which leads to the highest growth in the global market.
The veterinary reference laboratories segment accounted for the largest share of the global veterinary diagnostics market
Based on end users, the market is segmented into veterinary reference laboratories, veterinary hospitals & clinics, point-of-care testing/in-house testing, and veterinary research institutes & universities. Veterinary reference laboratories are the major end users in the global market, accounting for a share. Complex and highly specialized diagnostic tests are performed only at a few large reference laboratories across the world. Reference laboratories provide a wide array of testing services that may not be possible in clinics and hospitals, which leads to the largest share in the global market.
To know about the assumptions considered for the study, download the pdf brochure
North America is expected to account for the largest share of the veterinary diagnostics market
North America dominated the veterinary diagnostics market with the largest share. The global market in North America is characterized by the increasing population of companion and food-producing animals, rising meat and dairy product consumption, the availability of technologically advanced veterinary reference laboratories, rising veterinary healthcare expenditure, and growth in pet insurance coverage.
The prominent players in the veterinary diagnostics market are IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), Thermo Fisher Scientific Inc. (US), bioMérieux SA (France), Heska Corporation (US), NEOGEN Corporation (US), Bio-Rad Laboratories Inc. (US), Virbac (France), FUJIFILM Holdings Corporation (Japan), Shenzhen Mindray Animal Medical Technology Co. Ltd. (China), INDICAL BIOSCIENCE GmbH (Germany), BioNote, Inc. (South Korea), Biogal Galed Labs (Israel), Agrolabo S.p.A. (Italy), IDvet (France), Randox Laboratories Ltd. (Ireland), BioChek (Netherlands), Fassisi GmbH (Germany), Alvedia (France), SKYER, Inc. (South Korea), Shenzhen Bioeasy Biotechnology Co., Ltd. (China), Biopanda Reagents (UK), Precision Biosensor Inc. (South Korea), Skyla Corporation (China), and EUROIMMUN Medizinische Labordiagnostika AG (Germany).
Veterinary Diagnostics Market Report Scope
|
Report Metric |
Details |
|
Market Revenue in 2022 |
$2.8 billion |
|
Projected Revenue by 2027 |
$4.4 billion |
|
Revenue Rate |
Poised to grow at a CAGR of 9.2% |
|
Market Driver |
Increasing disease control & disease prevention measures |
|
Market Opportunity |
Increased use of PCR testing panels to rule out COVID-19 virus in animals |
The study categorizes the veterinary diagnostics market to forecast revenue and analyze trends in each of the following submarkets:
By Product
- Consumables
- Instruments
By Technology
-
Immunodiagnostics
-
Lateral Flow Assays
- Lateral Flow Rapid Tests
- Lateral Flow Strip Readers
- ELISA Tests
- Allergen-specific Immunodiagnostic Tests
- Immunoassay Analyzers
- Other Immunodiagnostic Products
-
Lateral Flow Assays
-
Clinical Biochemistry
-
Clinical Chemistry Analysis
- Clinical Chemistry Reagent Clips and Cartridges
- Clinical Chemistry Analyzers
-
Glucose Monitoring
- Blood Glucose Strips
- Glucose Monitors
- Urine Glucose Strips
-
Blood Gas & Electrolyte Analysis
- Blood Gas and Electrolyte Reagent Clips and Cartridges
- Blood Gas & Electrolyte Analyzers
-
Clinical Chemistry Analysis
-
Molecular Diagnostics
- Ploymerase Chain Reaction (PCR) Tests
- Microarrays
- Other Molecular Diagnostic Products
-
Hematology
- Hematology Cartridges
- Hematology Analyzers
-
Urinalysis
- Urinalysis Clips & Cartridges/Panels
- Urine Analyzers
- Urine Test Strips
- Other Veterinary Diagnostic Technologies
By Animal Type
-
Companion Animals
- Dogs
- Cats
- Horses
- Other Companion Animals
-
Livestock
- Cattle
- Pigs
- Poultry
- Other Livestock
By End User
- Veterinary Reference Laboratories
- Veterinary Hospitals & Clinics
- Point-of-care/ In-house Testing
- Veterinary Research Institutes & Universities
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- Japan
- China
- India
- Rest of Asia Pacific
-
Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Recent Developments
- In September 2021, Heska Corporation acquired Biotech Laboratories to strengthen its portfolio of rapid assay point-of-care diagnostics.
- In January 2021, Heska Corporation acquired Lacuna Diagnostics to strengthen its portfolio of point-of-care digital cytology technology and telemedicine services.
- In July 2020, Zoetis acquired Virtual Recall to strengthen its product portfolio and help veterinary practices improve their service offerings and communication with pet owners.
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the veterinary diagnostics market?
The veterinary diagnostics market boasts a total revenue value of $4.4 billion by 2027.
What is the estimated growth rate (CAGR) of the veterinary diagnostics market?
The global veterinary diagnostics market has an estimated compound annual growth rate (CAGR) of 9.2% and a revenue size in the region of $2.8 billion in 2022.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 54)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 59)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from Primary Experts
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS, BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
FIGURE 8 SUPPLY-SIDE ANALYSIS OF TOP COMPANIES: VETERINARY DIAGNOSTICS MARKET (2021)
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL MARKET (2022–2027)
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 11 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 12 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: GLOBAL MARKET
3 EXECUTIVE SUMMARY (Page No. - 73)
FIGURE 13 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 14 GLOBAL MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
FIGURE 15 GLOBAL MARKET, BY ANIMAL TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 16 GLOBAL MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF GLOBAL MARKET
4 PREMIUM INSIGHTS (Page No. - 77)
4.1 VETERINARY DIAGNOSTICS MARKET OVERVIEW
FIGURE 18 GROWING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: MARKET, BY END USER AND COUNTRY (2021)
FIGURE 19 VETERINARY REFERENCE LABORATORIES ACCOUNTED FOR LARGEST SHARE OF APAC MARKET IN 2021
4.3 GLOBAL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH IN GLOBAL MARKET DURING FORECAST PERIOD
4.4 GLOBAL MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 81)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 VETERINARY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Growth in companion animal population
TABLE 3 PET POPULATION, BY ANIMAL, 2014–2020 (MILLION)
5.2.1.2 Rising demand for animal-derived food products
TABLE 4 PAST AND PROJECTED TRENDS IN CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING COUNTRIES
TABLE 5 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
TABLE 6 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
5.2.1.3 Increasing incidence of transboundary and zoonotic diseases
TABLE 7 ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2019)
5.2.1.4 Rising demand for pet insurance and growing animal health expenditure
TABLE 8 US: AVERAGE PREMIUMS PAID (2019–2021)
FIGURE 23 CANADA: AVERAGE ANNUAL PREMIUMS, 2017–2021
FIGURE 24 US: PET INDUSTRY EXPENDITURE, 2010–2021
TABLE 9 US: BREAKDOWN OF PET INDUSTRY EXPENDITURE, 2020 VS. 2021 (USD BILLION)
TABLE 10 NORTH AMERICA: PET HEALTH INSURANCE MARKET, 2012–2021 (USD MILLION)
5.2.1.5 Growing number of veterinary practitioners and rising income levels in developed economies
TABLE 11 NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–2018
5.2.1.6 Increasing disease control and disease prevention measures
TABLE 12 MARKET DRIVERS: IMPACT ANALYSIS
5.2.2 MARKET RESTRAINTS
5.2.2.1 Rising pet care costs
FIGURE 25 US: BASIC ANNUAL EXPENSES FOR DOGS AND CATS, 2021
5.2.2.2 High costs of veterinary diagnostic tests
TABLE 13 MARKET RESTRAINTS: IMPACT ANALYSIS
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Increased use of PCR testing panels to rule out COVID-19 virus in animals
5.2.3.2 Untapped emerging markets
TABLE 14 MARKET OPPORTUNITIES: IMPACT ANALYSIS
5.2.4 MARKET CHALLENGES
5.2.4.1 Lack of animal healthcare awareness in emerging countries
5.2.4.2 Shortage of veterinary practitioners in developing markets
TABLE 15 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS. 2014 VS. 2018
TABLE 16 MARKET CHALLENGES: IMPACT ANALYSIS
5.3 INDUSTRY TRENDS
5.3.1 ADOPTION OF MULTIPLE TESTING PANELS
TABLE 17 MULTIPLE TESTING PANELS VS. SINGLE TESTING PANELS
5.3.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES
5.3.3 GROWING CONSOLIDATION IN VETERINARY DIAGNOSTICS INDUSTRY
TABLE 18 MAJOR ACQUISITIONS IN ANIMAL HEALTH DIAGNOSTICS INDUSTRY
5.3.4 GROWING SCALE OF VETERINARY BUSINESSES
5.4 DISEASE TRENDS
5.4.1 LIVESTOCK
5.4.1.1 Avian Influenza (AI)
5.4.1.2 African Swine Fever (ASF)
5.4.1.3 Bovine Babesiosis (BB)
5.4.1.4 Peste des Petits Ruminants (PPR)
5.4.1.5 West Nile Virus (WNV)
5.4.2 COMPANION ANIMALS
5.4.2.1 Zoonotic diseases
TABLE 19 COMMON ZOONOTIC DISEASES SPREAD BY COMPANION ANIMALS
5.4.2.2 Obesity & diabetes
5.5 TECHNOLOGICAL ANALYSIS
5.5.1 KEY TECHNOLOGIES
5.5.1.1 Development of portable instruments for POC diagnostic services
TABLE 20 PONT-OF-CARE PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS
5.5.2 ADJACENT TECHNOLOGIES
5.5.2.1 Development of rapid and sensitive veterinary diagnostic kits
5.6 PRICING ANALYSIS
TABLE 21 REGIONAL PRICING ANALYSIS OF VETERINARY ANALYZERS, 2021 (USD)
5.6.1 AVERAGE SELLING PRICES OF KEY PLAYERS, BY APPLICATION
TABLE 22 AVERAGE SELLING PRICES OF KEY PLAYERS FOR TOP 3 APPLICATIONS (USD)
5.7 VALUE CHAIN ANALYSIS
FIGURE 26 VETERINARY DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
5.8 ECOSYSTEM MARKET MAP
FIGURE 27 GLOBAL MARKET: ECOSYSTEM PARTICIPANTS
FIGURE 28 GLOBAL MARKET: ECOSYSTEM MARKET MAP
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 23 GLOBAL MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT FROM NEW ENTRANTS
5.9.2 THREAT FROM SUBSTITUTES
5.9.3 BARGAINING POWER OF SUPPLIERS
5.9.4 BARGAINING POWER OF BUYERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 SUPPLY CHAIN ANALYSIS
FIGURE 29 GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
5.11 REGULATORY ANALYSIS
5.11.1 US
5.11.2 EUROPE
5.12 PATENT ANALYSIS
5.12.1 PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS
FIGURE 30 PATENT PUBLICATION TRENDS (JANUARY 2011–AUGUST 2022)
5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 31 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY DIAGNOSTIC PATENTS (JANUARY 2011–JULY 2022)
FIGURE 32 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY DIAGNOSTIC PATENTS (JANUARY 2011–JULY 2022)
5.13 KEY CONFERENCES & EVENTS DURING 2022–2023
TABLE 24 GLOBAL MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.14 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.14.1 NORTH AMERICA
TABLE 25 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.14.2 EUROPE
TABLE 26 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.14.3 REST OF THE WORLD
TABLE 27 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 33 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS
TABLE 28 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS
5.15.2 BUYING CRITERIA
FIGURE 34 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
TABLE 29 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
6 VETERINARY DIAGNOSTICS MARKET, BY PRODUCT (Page No. - 118)
6.1 INTRODUCTION
TABLE 30 GLOBAL MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 CONSUMABLES
6.2.1 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF VETERINARY DIAGNOSTIC PRODUCTS MARKET
TABLE 31 KEY VETERINARY DIAGNOSTIC CONSUMABLES AVAILABLE IN MARKET (2021)
TABLE 32 VETERINARY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 INSTRUMENTS
6.3.1 INCREASING POINT-OF-CARE APPLICATIONS FOR EARLY DIAGNOSIS AND PRECISION IN LIVESTOCK FARMING TO DRIVE MARKET GROWTH
TABLE 33 KEY VETERINARY DIAGNOSTIC INSTRUMENTS AVAILABLE IN MARKET (2021)
TABLE 34 VETERINARY DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 VETERINARY DIAGNOSTICS MARKET, BY TECHNOLOGY (Page No. - 124)
7.1 INTRODUCTION
TABLE 35 GLOBAL MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 36 GLOBAL MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2 CLINICAL BIOCHEMISTRY
TABLE 37 KEY VETERINARY CLINICAL BIOCHEMISTRY PRODUCTS AVAILABLE IN MARKET
TABLE 38 VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 39 VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1 CLINICAL CHEMISTRY ANALYSIS
TABLE 40 CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 41 CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1.1 Clinical chemistry reagent clips & cartridges
7.2.1.1.1 Rising number of screening tests performed to drive market growth
TABLE 42 CLINICAL CHEMISTRY REAGENT CLIPS & CARTRIDGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1.2 Clinical chemistry analyzers
7.2.1.2.1 Increasing installation of clinical chemistry analyzers to propel growth
TABLE 43 CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2 GLUCOSE MONITORING
TABLE 44 GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 45 GLUCOSE MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2.1 Blood glucose strips
7.2.2.1.1 Growing demand for blood glucose strips in home care settings to drive growth
TABLE 46 BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2.2 Glucose monitors
7.2.2.2.1 Growing incidence of diabetes in pet animals to drive adoption of glucose monitors
TABLE 47 GLUCOSE MONITORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2.3 Urine glucose strips
7.2.2.3.1 Growing risk of DKA in animals to drive market growth
TABLE 48 URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3 BLOOD GAS & ELECTROLYTE ANALYSIS
TABLE 49 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 50 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.1 Blood gas & electrolyte reagent clips and cartridges
7.2.3.1.1 Easy availability of animal species-specific preloaded reagent clips to support market
TABLE 51 BLOOD GAS & ELECTROLYTE REAGENT CLIPS AND CARTRIDGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3.2 Blood gas & electrolyte analyzers
7.2.3.2.1 Growing use of blood gas & electrolyte analyzers to determine oxygen and carbon dioxide levels in blood to drive growth
TABLE 52 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 IMMUNODIAGNOSTICS
TABLE 53 KEY VETERINARY IMMUNODIAGNOSTIC PRODUCTS AVAILABLE IN MARKET
TABLE 54 VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 55 VETERINARY IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.1 LATERAL FLOW ASSAYS
TABLE 56 LATERAL FLOW ASSAYS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.1.1 Lateral flow rapid tests
7.3.1.1.1 Lateral flow rapid tests to dominate market during forecast period
TABLE 58 LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.1.2 Lateral flow strip readers
7.3.1.2.1 Growing need of lateral flow strip readers to determine quantity of analytes in samples to drive adoption
TABLE 59 LATERAL FLOW STRIP READERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.2 ELISA TESTS
7.3.2.1 Advantages such as cost-effectiveness and ease of use to drive demand for ELISA tests
TABLE 60 ELISA TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS
7.3.3.1 Increasing incidence of allergies in companion animals to drive market growth
TABLE 61 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.4 IMMUNOASSAY ANALYZERS
7.3.4.1 Growing use of immunoassay analyzers for livestock to propel market
TABLE 62 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.5 OTHER IMMUNODIAGNOSTIC PRODUCTS
TABLE 63 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 MOLECULAR DIAGNOSTICS
TABLE 64 VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 65 VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.1 PCR TESTS
7.4.1.1 Increased laboratory usage of PCR in proteomics and genomics to support growth
TABLE 66 PCR TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.2 MICROARRAYS
7.4.2.1 Growing applications of biochips for infectious disease identification to propel market
TABLE 67 MICROARRAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.4.3 OTHER MOLECULAR DIAGNOSTIC PRODUCTS
TABLE 68 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 HEMATOLOGY
TABLE 69 KEY VETERINARY HEMATOLOGY PRODUCTS AVAILABLE IN MARKET
TABLE 70 VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 71 VETERINARY HEMATOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.5.1 HEMATOLOGY CARTRIDGES
7.5.1.1 Extensive use of hematology cartridges along with hematology analyzers for complete blood analysis to fuel growth
TABLE 72 HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.5.2 HEMATOLOGY ANALYZERS
7.5.2.1 High usage of hematology analyzers by veterinary hospitals & clinics to support growth
TABLE 73 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.6 URINALYSIS
TABLE 74 KEY VETERINARY URINALYSIS PRODUCTS AVAILABLE IN MARKET
TABLE 75 VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 76 VETERINARY URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.6.1 URINALYSIS CLIPS & CARTRIDGES/PANELS
7.6.1.1 Growing use of clips and cartridges in urine analyzers to detect single or multiple electrolytes to drive market
TABLE 77 URINALYSIS CLIPS & CARTRIDGES/PANELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.6.2 URINE ANALYZERS
7.6.2.1 Development of easy-to-use urine analyzers for POC testing to drive market growth
TABLE 78 URINE ANALYZERS MARKET, BY COUNTRY, 2020–2027 USD MILLION)
7.6.3 URINE TEST STRIPS
7.6.3.1 Rising occurrence of kidney diseases in cats and dogs to support market
TABLE 79 URINE TEST STRIPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7.7 OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES
TABLE 80 OTHER VETERINARY DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
8 VETERINARY DIAGNOSTICS MARKET, BY ANIMAL TYPE (Page No. - 165)
8.1 INTRODUCTION
TABLE 81 GLOBAL MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
8.2 COMPANION ANIMALS
TABLE 82 GLOBAL MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 83 GLOBAL MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.1 DOGS
8.2.1.1 Largest number of pets insured were dogs in 2020—a key factor driving market growth
TABLE 84 DOG POPULATION, BY COUNTRY, 2012–2020 (MILLION)
TABLE 85 VETERINARY DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.2 CATS
8.2.2.1 Growing pet cat population to support growth
TABLE 86 CAT POPULATION, BY COUNTRY, 2012–2020 (MILLION)
TABLE 87 ANNUAL COSTS ASSOCIATED WITH CAT-BORNE DISEASES IN AUSTRALIA, 2020 (MILLION)
TABLE 88 GLOBAL MARKET FOR CATS, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.3 HORSES
8.2.3.1 Growing equine health awareness to drive growth
TABLE 89 EQUINE POPULATION, BY COUNTRY, 2012–2019 (THOUSAND)
FIGURE 35 NUMBER OF PRIVATE EQUINE CLINICAL PRACTICES IN US, 2009–2020
TABLE 90 GLOBAL MARKET FOR HORSES, BY COUNTRY, 2020–2027 (USD MILLION)
8.2.4 OTHER COMPANION ANIMALS
TABLE 91 GLOBAL MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 LIVESTOCK
TABLE 92 GLOBAL MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 GLOBAL MARKET FOR LIVESTOCK, BY COUNTRY, 2020–2027 (USD MILLION)
8.3.1 CATTLE
8.3.1.1 Growing consumption of meat to support market growth
FIGURE 36 MEAT PRODUCTION, BY TYPE, 2019–2020 (THOUSAND TONNES)
TABLE 94 CATTLE POPULATION, BY COUNTRY, 2012–2019 (MILLION)
FIGURE 37 MILK PRODUCTION, BY REGION, 2016–2020 (THOUSAND TONNES)
TABLE 95 VETERINARY DIAGNOSTICS MARKET FOR CATTLE, BY COUNTRY, 2020–2027 (USD MILLION)
8.3.2 PIGS
8.3.2.1 Growing incidence of infectious diseases to drive market growth
TABLE 96 SWINE POPULATION, BY COUNTRY, 2012–2019 (MILLION)
FIGURE 38 ANNUAL PER CAPITA MEAT CONSUMPTION PROJECTIONS, DEVELOPING VS. DEVELOPED COUNTRIES, 2020–2030
TABLE 97 GLOBAL MARKET FOR PIGS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3.3 POULTRY
8.3.3.1 Increasing demand for poultry meat to contribute to market growth
TABLE 98 POULTRY POPULATION, BY COUNTRY, 2012–2019 (MILLION)
ABLE 99 GLOBAL MARKET FOR POULTRY, BY COUNTRY, 2020–2027 (USD MILLION)
8.3.4 OTHER LIVESTOCK ANIMALS
TABLE 100 GLOBAL MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2020–2027 (USD MILLION)
9 VETERINARY DIAGNOSTICS MARKET, BY END USER (Page No. - 185)
9.1 INTRODUCTION
TABLE 101 GLOBAL MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2 VETERINARY REFERENCE LABORATORIES
9.2.1 LARGE VOLUME OF SAMPLES RECEIVED BY VETERINARY REFERENCE LABORATORIES TO DRIVE MARKET GROWTH
TABLE 102 GLOBAL MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 VETERINARY HOSPITALS & CLINICS
9.3.1 GROWING PET OWNERSHIP AND SPENDING ON PET CARE TO PROPEL MARKET
FIGURE 39 US: GROWING NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES (2012–2020)
TABLE 103 GLOBAL MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
9.4 POINT-OF-CARE/IN-HOUSE TESTING
9.4.1 EASE OF USE, COST-EFFECTIVENESS, AND SWIFT RESULTS OFFERED BY POINT-OF-CARE TESTS TO DRIVE DEMAND
TABLE 104 GLOBAL MARKET FOR POINT-OF-CARE/IN-HOUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION)
9.5 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES
9.5.1 INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND VETERINARY RESEARCH INSTITUTES TO SUPPORT GROWTH
TABLE 105 GLOBAL MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2020–2027 (USD MILLION)
10 VETERINARY DIAGNOSTICS MARKET, BY REGION (Page No. - 192)
10.1 INTRODUCTION
TABLE 106 GLOBAL MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 40 EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA
FIGURE 41 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET SNAPSHOT
TABLE 107 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 108 NORTH AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 109 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 110 NORTH AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 111 NORTH AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 112 NORTH AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 NORTH AMERICA: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 114 NORTH AMERICA: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 115 NORTH AMERICA: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 116 NORTH AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 117 NORTH AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 118 NORTH AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 119 NORTH AMERICA: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 120 NORTH AMERICA: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 121 NORTH AMERICA: MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 NORTH AMERICA: VETERINARY DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 US to dominate North American veterinary diagnostics market during forecast period
FIGURE 42 US: POPULATION OF DOGS, 2012–2020 (MILLION)
FIGURE 43 US: EXPENDITURE ON VET VISITS
TABLE 123 HEALTHCARE EXPENDITURE ON COMPANION ANIMALS, 2018 VS. 2020
FIGURE 44 INCOME OF VETERINARIANS IN US, 2017–2021
FIGURE 45 NUMBER OF VETERINARIANS IN US, 2016–2020
TABLE 124 US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION)
TABLE 125 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES, 2014–2020
TABLE 126 US: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 127 US: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 128 US: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 129 US: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 130 US: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 131 US: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 132 US: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 133 US: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 134 US: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 135 US: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 136 US: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 137 US: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 138 US: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 139 US: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 US: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Growing pet adoption in Canada to drive market growth
FIGURE 46 CANADA: COMPANION ANIMAL POPULATION, 2016–2020 (MILLION)
TABLE 141 CANADA: LARGE ANIMAL POPULATION, 2001–2019 (MILLION)
TABLE 142 CANADA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 143 CANADA: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 144 CANADA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 145 CANADA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 146 CANADA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 147 CANADA: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 148 CANADA: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 149 CANADA: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 150 CANADA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 151 CANADA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 152 CANADA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 153 CANADA: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 154 CANADA: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 155 CANADA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 156 CANADA: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3 EUROPE
TABLE 157 EUROPE: COMPANION POPULATION, 2019 (MILLION)
TABLE 158 EUROPE: LIVESTOCK POPULATION, 2019 (MILLION)
FIGURE 47 EU27: LIVESTOCK POPULATION, 2012–2019 (MILLION)
TABLE 159 EUROPE: NUMBER OF VETERINARIANS, 2012–2019
TABLE 160 EUROPE: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 161 EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 162 EUROPE: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 163 EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 164 EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 165 EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 EUROPE: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 167 EUROPE: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 168 EUROPE: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 169 EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 170 EUROPE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 171 EUROPE: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 172 EUROPE: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 173 EUROPE: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 174 EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 175 EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Rising awareness of zoonotic diseases to drive market growth
TABLE 176 GERMANY: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 177 GERMANY: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 178 GERMANY: NUMBER OF VETERINARIANS, 2014 VS. 2019
TABLE 179 GERMANY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 180 GERMANY: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 181 GERMANY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 182 GERMANY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 183 GERMANY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 184 GERMANY: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 185 GERMANY: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 186 GERMANY: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 187 GERMANY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 188 GERMANY: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 189 GERMANY: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 190 GERMANY: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 191 GERMANY: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 192 GERMANY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 193 GERMANY: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.2 UK
10.3.2.1 Increasing pet ownership to make UK relatively large market for veterinary diagnostics
TABLE 194 UK: PET POPULATION, 2017–2020 (MILLION)
TABLE 195 UK: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 196 UK: NUMBER OF VETERINARIANS, 2014 VS. 2019
TABLE 197 UK: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 198 UK: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 199 UK: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 200 UK: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 201 UK: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 202 UK: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 203 UK: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 204 UK: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 205 UK: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 206 UK: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 207 UK: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 208 UK: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 209 UK: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 210 UK: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 211 UK: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Willingness of pet owners to spend on health of companion pets to contribute to growth
TABLE 212 FRANCE: PET POPULATION, 2017–2020 (MILLION)
TABLE 213 FRANCE: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 214 FRANCE: NUMBER OF VETERINARIANS, 2014 VS. 2017
TABLE 215 FRANCE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 216 FRANCE: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 217 FRANCE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 218 FRANCE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 219 FRANCE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 220 FRANCE: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 221 FRANCE: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 222 FRANCE: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 223 FRANCE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 224 FRANCE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 225 FRANCE: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 226 FRANCE: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 227 FRANCE: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 228 FRANCE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 229 FRANCE: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Rising awareness about pet healthcare to propel market growth
TABLE 230 ITALY: PET POPULATION, 2017–2020 (MILLION)
TABLE 231 ITALY: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 232 ITALY: NUMBER OF VETERINARIANS, 2012 VS. 2017
TABLE 233 ITALY: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 234 ITALY: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 235 ITALY: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 236 ITALY: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 237 ITALY: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 238 ITALY: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 239 ITALY: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 240 ITALY: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 241 ITALY: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 242 ITALY: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 243 ITALY: VETERINARY URINALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 244 ITALY: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 245 ITALY: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 246 ITALY: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 247 ITALY: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Growing demand for pig and poultry products to aid adoption of veterinary diagnostic products
TABLE 248 SPAIN: PET POPULATION, 2017–2020 (MILLION)
TABLE 249 SPAIN: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)
TABLE 250 SPAIN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 251 SPAIN: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 252 SPAIN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 253 SPAIN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 254 SPAIN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 255 SPAIN: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 256 SPAIN: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 257 SPAIN: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 258 SPAIN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 259 SPAIN: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 260 SPAIN: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 261 SPAIN: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 262 SPAIN: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 263 SPAIN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 264 SPAIN: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 265 REST OF EUROPE: COMPANION ANIMAL OWNERSHIP, BY COUNTRY, 2019 (MILLION)
TABLE 266 REST OF EUROPE: LIVESTOCK POPULATION, BY COUNTRY, 2019 (MILLION)
TABLE 267 REST OF EUROPE: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, 2010 VS. 2019
TABLE 268 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 269 REST OF EUROPE: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 270 REST OF EUROPE: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 271 REST OF EUROPE: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 272 REST OF EUROPE: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 273 REST OF EUROPE: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 274 REST OF EUROPE: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 275 REST OF EUROPE: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 276 REST OF EUROPE: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 277 REST OF EUROPE: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 278 REST OF EUROPE: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 279 REST OF EUROPE: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 280 REST OF EUROPE: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 281 REST OF EUROPE: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 282 REST OF EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 48 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET SNAPSHOT
TABLE 283 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 284 ASIA PACIFIC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 285 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 286 ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 287 ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 288 ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 289 ASIA PACIFIC: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 290 ASIA PACIFIC: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 291 ASIA PACIFIC: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 292 ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 293 ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 294 ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 295 ASIA PACIFIC: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 296 ASIA PACIFIC: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 297 ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 298 ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.1 CHINA
10.4.1.1 Large pool of food-producing animals in China to drive market
TABLE 299 CHINA: LIVESTOCK POPULATION, 2010–2019 (MILLION)
TABLE 300 CHINA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 301 CHINA: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 302 CHINA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 303 CHINA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 304 CHINA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 305 CHINA: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 306 CHINA: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 307 CHINA: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 308 CHINA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 309 CHINA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 310 CHINA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 311 CHINA: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 312 CHINA: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 313 CHINA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 314 CHINA: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Rising awareness about zoonotic diseases and increased pet expenditure to further market growth
TABLE 315 NUMBER OF DOMESTICATED DOGS AND CATS IN JAPAN, 2012–2020 (THOUSAND)
TABLE 316 PRODUCTION, CONSUMPTION, IMPORT, AND EXPORT OF ANIMAL-DERIVED FOOD PRODUCTS IN JAPAN, 2000 VS. 2030 (THOUSAND METRIC TONS)
TABLE 317 JAPAN: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 318 JAPAN: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 319 JAPAN: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 320 JAPAN: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 321 JAPAN: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 322 JAPAN: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 323 JAPAN: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 324 JAPAN: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 325 JAPAN: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 326 JAPAN: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 327 JAPAN: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 328 JAPAN: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 329 JAPAN: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 330 JAPAN: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 331 JAPAN: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Growing demand for livestock products to make India major market for veterinary diagnostics
TABLE 332 INDIA: LIVESTOCK POPULATION, 2007–2019 (MILLION)
TABLE 333 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
TABLE 334 INDIA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 335 INDIA: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 336 INDIA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 337 INDIA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 338 INDIA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 339 INDIA: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 340 INDIA: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 341 INDIA: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 342 INDIA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 343 INDIA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 344 INDIA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 345 INDIA: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 346 INDIA: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 347 INDIA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 348 INDIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.4 REST OF APAC
TABLE 349 REST OF ASIA PACIFIC: LIVESTOCK POPULATION, BY COUNTRY, 2010–2019 (MILLION)
TABLE 350 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 351 REST OF ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 352 REST OF ASIA PACIFIC: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 353 REST OF ASIA PACIFIC: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 354 REST OF ASIA PACIFIC: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 355 REST OF ASIA PACIFIC: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 356 REST OF ASIA PACIFIC: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 357 REST OF ASIA PACIFIC: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 358 REST OF ASIA PACIFIC: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 359 REST OF ASIA PACIFIC: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 360 REST OF ASIA PACIFIC: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 361 REST OF ASIA PACIFIC: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 362 REST OF ASIA PACIFIC: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 363 REST OF ASIA PACIFIC: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 364 REST OF ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
TABLE 365 LATIN AMERICA: LIVESTOCK POPULATION, BY COUNTRY, 2010–2019 (MILLION)
TABLE 366 LATIN AMERICA: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, 2010 VS. 2019
TABLE 367 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 368 LATIN AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 369 LATIN AMERICA: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 370 LATIN AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 371 LATIN AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 372 LATIN AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 373 LATIN AMERICA: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 374 LATIN AMERICA: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 375 LATIN AMERICA: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 376 LATIN AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 377 LATIN AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 378 LATIN AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 379 LATIN AMERICA: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 380 LATIN AMERICA: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 381 LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 382 LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 Well-established and rapidly growing livestock industry in Brazil to promote growth
TABLE 383 BRAZIL: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 384 BRAZIL: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 385 BRAZIL: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 386 BRAZIL: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 387 BRAZIL: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 388 BRAZIL: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 389 BRAZIL: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 390 BRAZIL: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 391 BRAZIL: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 392 BRAZIL: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 393 BRAZIL: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 394 BRAZIL: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 395 BRAZIL: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 396 BRAZIL: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 397 BRAZIL: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 Mexico to continue to be second-largest pet care market in Latin America during forecast period
TABLE 398 MEXICO: LIVESTOCK POPULATION, 2010–2019 (MILLION)
TABLE 399 MEXICO: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 400 MEXICO: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 401 MEXICO: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 402 MEXICO: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 403 MEXICO: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 404 MEXICO: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 405 MEXICO: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 406 MEXICO: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 407 MEXICO: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 408 MEXICO: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 409 MEXICO: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 410 MEXICO: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 411 MEXICO: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 412 MEXICO: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 413 MEXICO: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
TABLE 414 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 415 REST OF LATIN AMERICA: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 416 REST OF LATIN AMERICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 417 REST OF LATIN AMERICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 418 REST OF LATIN AMERICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 419 REST OF LATIN AMERICA: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 420 REST OF LATIN AMERICA: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 421 REST OF LATIN AMERICA: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 422 REST OF LATIN AMERICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 423 REST OF LATIN AMERICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 424 REST OF LATIN AMERICA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 425 REST OF LATIN AMERICA: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 426 REST OF LATIN AMERICA: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 427 REST OF LATIN AMERICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 428 REST OF LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
TABLE 429 MIDDLE EAST: LIVESTOCK POPULATION, 2010 VS. 2019 (MILLION)
TABLE 430 MIDDLE EAST: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, 2010 VS. 2018
TABLE 431 AFRICA: FOOD-PRODUCING ANIMAL POPULATION, 2012–2019 (MILLION)
TABLE 432 AFRICA: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, 2010–2018
TABLE 433 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 434 MIDDLE EAST & AFRICA: MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
TABLE 435 MIDDLE EAST & AFRICA: VETERINARY IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 436 MIDDLE EAST & AFRICA: VETERINARY LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 437 MIDDLE EAST & AFRICA: VETERINARY CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 438 MIDDLE EAST & AFRICA: VETERINARY CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 439 MIDDLE EAST & AFRICA: VETERINARY GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 440 MIDDLE EAST & AFRICA: VETERINARY BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 441 MIDDLE EAST & AFRICA: VETERINARY MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 442 MIDDLE EAST & AFRICA: VETERINARY HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 443 MIDDLE EAST & AFRICA: VETERINARY URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 444 MIDDLE EAST & AFRICA: MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION)
TABLE 445 MIDDLE EAST & AFRICA: MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 446 MIDDLE EAST & AFRICA: VETERINARY DIAGNOSTICS MARKET FOR LIVESTOCK, BY TYPE, 2020–2027 (USD MILLION)
TABLE 447 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 337)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 49 REVENUE ANALYSIS OF TOP PLAYERS IN VETERINARY DIAGNOSTICS MARKET
11.4 MARKET SHARE ANALYSIS
FIGURE 50 VETERINARY DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2021
11.5 COMPANY EVALUATION QUADRANT
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 51 VETERINARY DIAGNOSTICS MARKET: COMPANY EVALUATION QUADRANT (2021)
11.6 COMPANY EVALUATION QUADRANT FOR START-UPS
11.6.1 PROGRESSIVE COMPANIES
11.6.2 DYNAMIC COMPANIES
11.6.3 STARTING BLOCKS
11.6.4 RESPONSIVE COMPANIES
FIGURE 52 VETERINARY DIAGNOSTICS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS (2021)
11.7 COMPANY PRODUCT FOOTPRINT
TABLE 448 PRODUCT PORTFOLIO ANALYSIS: GLOBAL MARKET
11.8 TECHNOLOGY FOOTPRINT OF MAJOR PLAYERS
TABLE 449 TECHNOLOGY FOOTPRINT: GLOBAL MARKET (2021)
11.9 END-USER FOOTPRINT OF MAJOR PLAYERS
TABLE 450 END-USER FOOTPRINT: GLOBAL MARKET (2021)
11.1 REGIONAL FOOTPRINT OF MAJOR PLAYERS
TABLE 451 REGIONAL FOOTPRINT: GLOBAL MARKET (2021)
11.11 COMPETITIVE BENCHMARKING
TABLE 452 VETERINARY DIAGNOSTICS MARKET: DETAILED LIST OF KEY START-UPS/SMES
11.12 COMPETITIVE SCENARIO
11.12.1 PRODUCT LAUNCHES
TABLE 453 PRODUCT LAUNCHES & APPROVALS, 2019–2022
11.12.2 DEALS
TABLE 454 DEALS, 2019–2022
11.12.3 OTHER DEVELOPMENTS
TABLE 455 OTHER DEVELOPMENTS, 2019–2022
12 COMPANY PROFILES (Page No. - 354)
(Business overview, Products offered, Recent Developments, MNM view)*
12.1 KEY PLAYERS
12.1.1 IDEXX LABORATORIES, INC.
TABLE 456 IDEXX LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 53 IDEXX LABORATORIES: COMPANY SNAPSHOT (2021)
12.1.2 ZOETIS, INC.
TABLE 457 ZOETIS, INC.: BUSINESS OVERVIEW
FIGURE 54 ZOETIS, INC.: COMPANY SNAPSHOT (2021)
12.1.3 THERMO FISHER SCIENTIFIC, INC.
TABLE 458 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 55 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021)
12.1.4 HESKA CORPORATION
TABLE 459 HESKA CORPORATION: BUSINESS OVERVIEW
FIGURE 56 HESKA CORPORATION: COMPANY SNAPSHOT (2021)
12.1.5 BIOMÉRIEUX SA
TABLE 460 BIOMÉRIEUX SA: BUSINESS OVERVIEW
FIGURE 57 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2021)
12.1.6 NEOGEN CORPORATION
TABLE 461 NEOGEN CORPORATION: BUSINESS OVERVIEW
FIGURE 58 NEOGEN CORPORATION: COMPANY SNAPSHOT (2021)
12.1.7 BIO-RAD LABORATORIES, INC.
TABLE 462 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 59 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
12.1.8 VIRBAC
TABLE 463 VIRBAC: BUSINESS OVERVIEW
FIGURE 60 VIRBAC: COMPANY SNAPSHOT (2021)
12.1.9 FUJIFILM HOLDINGS CORPORATION
TABLE 464 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
FIGURE 61 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2021)
12.1.10 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.
TABLE 465 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
12.1.11 INDICAL BIOSCIENCE GMBH
TABLE 466 INDICAL BIOSCIENCE GMBH: BUSINESS OVERVIEW
12.1.12 BIONOTE INC.
TABLE 467 BIONOTE INC.: BUSINESS OVERVIEW
12.1.13 BIOGAL GALED LABS
TABLE 468 BIOGAL GALED LABS: BUSINESS OVERVIEW
12.1.14 AGROLABO S.P.A.
TABLE 469 AGROLABO S.P.A.: BUSINESS OVERVIEW
12.1.15 IDVET
TABLE 470 IDVET: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 RANDOX LABORATORIES LTD.
TABLE 471 RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW
12.2.2 BIOCHEK
TABLE 472 BIOCHEK: BUSINESS OVERVIEW
12.2.3 FASSISI GMBH
TABLE 473 FASSISI GMBH: BUSINESS OVERVIEW
12.2.4 ALVEDIA
TABLE 474 ALVEDIA: BUSINESS OVERVIEW
12.2.5 SKYER, INC.
TABLE 475 SKYER, INC.: BUSINESS OVERVIEW
12.2.6 SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD.
TABLE 476 SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
12.2.7 BIOPANDA REAGENTS
TABLE 477 BIOPANDA REAGENTS: BUSINESS OVERVIEW
12.2.8 PRECISION BIOSENSOR, INC.
TABLE 478 PRECISION BIOSENSOR, INC.: BUSINESS OVERVIEW
12.2.9 SKYLA CORPORATION
TABLE 479 SKYLA CORPORATION: BUSINESS OVERVIEW
12.2.10 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
TABLE 480 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG: BUSINESS OVERVIEW
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 441)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Secondary Research
This research study involved the usage of comprehensive secondary sources; directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for an extensive, technical, market-oriented, and commercial study of the veterinary diagnostics market. It was also used to obtain important information about the key players, market classification and segmentation according to industry trends to the bottommost level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side and demand side are detailed below.
A breakdown of the primary respondents is provided below:
Breakdown of Primary Interviews: Supply-Side Participants, By Company Type, Designation, and Region
Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.
Note 2: Other primaries include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2020: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 =
To know about the assumptions considered for the study, download the pdf brochure
Breakdown of Primary Interviews: Demand-Side Participants, By End User, Designation, and Region
Note: Others include department heads, research scientists, and professors.
Market Size Estimation
The total size of the veterinary diagnostics market was arrived at after data triangulation from two different approaches, as mentioned below. After each approach, the weighted average of all approaches was taken based on the level of assumptions used in each approach.
Data Triangulation
After arriving at the market size, the total market was divided into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and sub-segments, data triangulation and market breakdown procedures were employed, wherever applicable. The following figure shows the market validation, source structure, and data triangulation methodology implemented in this report’s market engineering process.
Objectives of the Study
- To define and measure the global veterinary diagnostics market by product, animal type, technology, end user, and region
- To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall veterinary diagnostics market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
-
To forecast the size of the veterinary diagnostics market in five main regions: North America, Europe, Asia Pacific, Latin America, and
the Middle East & Africa - To profile the key players in the veterinary diagnostics market and comprehensively analyze their core competencies2 and market shares
- To track and analyze company developments such as partnerships, collaborations, expansions, acquisitions, and product launches & upgrades
Available customizations
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the RoE market into Austria, Finland, and others
- Further breakdown of the RoAPAC market into Australia, South Korea, and others
- Further breakdown of the RoLATAM market into Argentina, Colombia, Chile, and others
- Competitive Landscape Assessment
- Market share analysis for the North America and Europe region, which provides market shares of the top 3–5 key players in the veterinary diagnostics market
- Competitive leadership mapping for established players in the US
Generating Response ...
Growth opportunities and latent adjacency in Veterinary Diagnostics Market
Which is the leading segment dominating the Veterinary Diagnostics Market?
Can you give some more information on the key factors impacting the Veterinary Diagnostics Market?
Which are the latest trends to focus for revenue expansion in Veterinary Diagnostics Market?